Research Article
Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
Table 3
Toxicity related to topotecan/cyclophosphamide chemotherapy.
| | Toxicity | Number () | Percentage (%) |
| | Febrile neutropenia | 5 | 33% | | Patient requiring transfusion | 7 | 47% | | Blood | 7 | 47% | | Platelets | 3 | 20% | | Discontinuation of therapy | 2 | 13% |
|
|
